This guideline covers the clinical care of adults (18 years and over) who are dying during the last 2 to 3 days of life.
GI Dynamics has announced its decision to discontinue its US pivotal clinical trial of EndoBarrier Therapy (the ENDO Trial) for...
GI Dynamics has initiated its U.S. multicenter pivotal clinical trial of EndoBarrier, the ENDO Trial, for the treatment of patients...
Purpose: Imbalance in the microbiota, dysbiosis, has been identified in inflammatory bowel disease (IBD).
Background and purpose: There is debate as to whether the apparent rebound after fingolimod discontinuation is related to the discontinuation itself or whether it is due to the natural course of highly active multiple sclerosis (MS). Our aim was to survey the prevalence of severe reactivation and rebound after discontinuation of fingolimod in a cohort of Italian patients with MS.
This guideline is restricted to GI endoscopy but we cover elective and acute or emergency procedures.
Vascular Dynamics announced European results of the company�s first-in-human trial of its Mobius HD implant in resistant hypertension has been...
This guideline covers the developmental follow-up of babies, children and young people under 18 years who were born preterm (before 37+0 weeks of pregnancy).
To update and expand the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the ICU.
GI Dynamics has received the initial top-line results from its U.S. pivotal clinical trial of EndoBarrier Therapy for glycemic improvement...